Schwartzberg Gil 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Apr 15, 2021
Insider Transaction Report
Form 4
Schwartzberg Gil
10% Owner
Transactions
- Award
Option to Purchase Common Stock
2021-04-09+250,000→ 250,000 totalExercise: $3.20From: 2021-04-09Exp: 2026-04-01→ Common (250,000 underlying)
Holdings
- 105,264
Warrant to Purchase Common Stock
Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (105,264 underlying) - 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying) - 83,333
Options to Purchase Common Stock
Exercise: $3.00From: 2016-01-28Exp: 2024-01-28→ Common (83,333 underlying) - 291,667(indirect: By Trust)
Options to Purchase Common Stock
Exercise: $3.00From: 2015-01-28Exp: 2024-01-28→ Common (291,667 underlying) - 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying)
Footnotes (1)
- [F1]On April 9, 2021, in connection with his appointment to the Company's Board of Directors, the reporting person was granted stock options to purchase an aggregate of 250,000 shares vesting 50% on the grant date and the remainder vesting on the last day of each subsequent calendar quarter until fully vested.